Teva CEO Discusses Drug Pipeline and NYSE Direct Listing

1. 1Teva Pharmaceutical Industries (TEVA.TA) CEO Richard Francis spoke with Bloomberg's Romaine Bostick.
2. 2He addressed the positive second-quarter results, the impact of Medicare rule changes on patients, and the new NYSE listing.
3. 3The impact of Medicare rule changes on patients is imminent, and TEVA.TA rose 10.17%.

Source Barrons.com +2 · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →